# Johnson & Johnson (JNJ) — Q2-2024 Earnings Results

**Report date:** 2024-07-17 (before market open)  
**Sector:** Health Care / Pharmaceuticals  
**Status:** reported  
**Source:** https://earningsnxt.ai/ticker/JNJ/earnings/Q2-2024

## Post-Earnings Brief

### Headline

Johnson & Johnson Beats on EPS, Stock Up 3.69%

### Key Numbers

| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $2.82 | N/A | +4.06% |
| Revenue | N/A | N/A | N/A |

### Management Commentary

**Tone:** Cautiously Optimistic

Management expressed satisfaction with the EPS results, highlighting their commitment to shareholder value. However, they did not provide specific guidance for future quarters.

**Key quotes:**

> We are pleased with our EPS performance this quarter.

> Our focus remains on delivering value to our shareholders.

### Guidance Changes

No forward guidance was provided in this earnings report.

### What It Means

Johnson & Johnson's strong EPS performance indicates effective cost management and operational efficiency, contributing to a positive stock reaction of 3.69%. The lack of revenue data and guidance may leave investors cautious, but the EPS beat suggests the company is on a solid path. Overall, the results reflect a resilient business amidst market challenges.

---

_AI-assisted analysis from EarningsNxt. Not financial advice. View full page: https://earningsnxt.ai/ticker/JNJ/earnings/Q2-2024_